标普和纳斯达克内在价值 联系我们

Pacira BioSciences, Inc. PCRX NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
45/100
0/7 Pass
SharesGrow Intrinsic Value
$12.11
-49%
Analyst Price Target
$27.00
+13.7%

Pacira BioSciences, Inc. (PCRX) 是一家上市公司 属于 医疗保健 板块,经营于 制药 - 专科与仿制药 行业. 公司总部位于 Tampa, FL, 美国. 现任CEO为 Frank D. Lee.

PCRX 拥有 IPO日期为 2011-02-03, 788 名全职员工, 在 NASDAQ Global Select, 市值为 $1.02B.

关于 Pacira BioSciences, Inc.

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

📍 5401 West Kennedy Boulevard, Tampa, FL 33609 📞 813 553 6680
公司详情
所属板块医疗保健
细分行业制药 - 专科与仿制药
国家美国
交易所NASDAQ Global Select
货币USD
IPO日期2011-02-03
首席执行官Frank D. Lee
员工数788
交易信息
当前价格$23.75
市值$1.02B
52周区间18.8-27.64
Beta0.20
ETF
ADR
CUSIP695127100
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言